Lido Advisors, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1650150 Los Angeles, CA

Position in TEVA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$693,489

+$85,156 QoQ

Shares Held

20,469

+1.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#363

of 671 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 10% Shared 0% None 90%

Healthcare · as of Jun 30, 2026

Lido Advisors, LLC holds $12,595,878 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	49,202	$5,458,469
2	UTHR	UNITED THERAPEUTICS Corp	1,812	$981,795
3	AQST	Aquestive Therapeutics, Inc.	215,316	$895,714
4	HROW	Harrow, Inc.	16,489	$700,287
5	TEVA	Teva Pharmaceutical Industries Ltd This page	20,469	$693,489
6	VTRS	Viatris Inc	40,486	$642,917
7	INDV	Indivior Pharmaceuticals, Inc.	13,628	$559,156
8	ZTS	Zoetis Inc.	7,722	$554,901

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$693,489	20,469	+1.3%	Shares	Defined	2026-08-07
2026-03-31	$608,333	20,197	+10.9%	Shares	Defined	2026-05-13
2025-12-31	$568,240	18,207	+0.4%	Shares	Defined	2026-02-10
2025-09-30	$366,428	18,140	-5.2%	Shares	Defined	2025-11-14
2025-06-30	$320,803	19,141	+0.2%	Shares	Defined	2025-08-13
2025-03-31	$293,536	19,098	-0.3%	Shares	Sole	2025-05-15
2024-12-31	$422,374	19,164	-0.2%	Shares	Sole	2025-02-14
2024-09-30	$346,092	19,206	+3.4%	Shares	Defined	2024-11-14
2024-06-30	$301,843	18,575	-3.5%	Shares	Defined	2024-08-15
2024-03-31	$271,532	19,244	-0.6%	Shares	Defined	2024-05-15
2023-12-31	$202,201	19,368	+15.2%	Shares	Sole	2024-02-14
2023-09-30	$171,482	16,812	+1.8%	Shares	Sole	2023-11-14
2023-06-30	$124,350	16,514	-1.6%	Shares	Sole	2023-08-09
2023-03-31	$148,467	16,776	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.